|
Iborra MA, García E, Carrilero B, Segovia M. [Malaria diagnosis and treatment: analysis of a cohort of hospitalised patients at a tertiary level hospital (1998-2010)]. Rev Esp Quimioter. 2013 Mar;26(1):6-11. Spanish. PubMed PMID: 23546456.
AÑO: 2013; IF: 0.905
|
23546456
|
Murcia L, Carrilero B, Saura D, Iborra MA, Segovia M. [Diagnosis and treatment of Chagas disease]. Enferm Infecc Microbiol Clin. 2013 Feb;31 Suppl 1:26-34. doi: 10.1016/S0213-005X(13)70111-3. Spanish. PubMed PMID: 23453228.
AÑO: 2013; IF: 1.881
|
|
Egui A, Thomas MC, Morell M, Marañón C, Carrilero B, Segovia M, Puerta CJ, Pinazo MJ, Rosas F, Gascón J, López MC. Trypanosoma cruzi paraflagellar rod proteins 2 and 3 contain immunodominant CD8(+) T-cell epitopes that are recognized by cytotoxic T cells from Chagas disease patients. Mol Immunol. 2012 Oct;52(3-4):289-98. doi: 10.1016/j.molimm.2012.05.021. Epub 2012 Jun 29. PubMed PMID: 22750229.
AÑO: 2012; IF: 2.645
|
|
Murcia L, Carrilero B, Albajar Viñas P, Segovia M. Nifurtimox chemotherapy: collateral effects in treated Trypanosoma cruzi infected patients. Rev Esp Quimioter. 2012 Mar;25(1):74-5. PubMed PMID: 22488545.
AÑO: 2012; IF: 0.836
|
|
Murcia L, Carrilero B, Segovia M. Limitations of currently available Chagas disease chemotherapy. Rev Esp Quimioter. 2012 Mar;25(1):1-3. PubMed PMID: 22488534.
AÑO: 2012; IF: 0.836
|